HUP0302910A3 - Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine - Google Patents
Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetineInfo
- Publication number
- HUP0302910A3 HUP0302910A3 HU0302910A HUP0302910A HUP0302910A3 HU P0302910 A3 HUP0302910 A3 HU P0302910A3 HU 0302910 A HU0302910 A HU 0302910A HU P0302910 A HUP0302910 A HU P0302910A HU P0302910 A3 HUP0302910 A3 HU P0302910A3
- Authority
- HU
- Hungary
- Prior art keywords
- racemisation
- tetrahydropyridine
- paroxetine
- fluorophenyl
- hydroxymethyl
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
- STCJUTRPNGTJGE-UHFFFAOYSA-N [1-benzyl-4-(4-fluorophenyl)-3,6-dihydro-2h-pyridin-3-yl]methanol Chemical compound C1C=C(C=2C=CC(F)=CC=2)C(CO)CN1CC1=CC=CC=C1 STCJUTRPNGTJGE-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960002296 paroxetine Drugs 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0021147.4A GB0021147D0 (en) | 2000-08-30 | 2000-08-30 | Chemical process |
| PCT/EP2001/009998 WO2002018338A1 (en) | 2000-08-30 | 2001-08-30 | Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0302910A2 HUP0302910A2 (hu) | 2004-01-28 |
| HUP0302910A3 true HUP0302910A3 (en) | 2008-02-28 |
Family
ID=9898420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0302910A HUP0302910A3 (en) | 2000-08-30 | 2001-08-30 | Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6949650B2 (https=) |
| EP (1) | EP1315701B1 (https=) |
| JP (1) | JP2004518620A (https=) |
| AT (1) | ATE421953T1 (https=) |
| AU (1) | AU2002213865A1 (https=) |
| CA (1) | CA2420579C (https=) |
| CZ (1) | CZ2003503A3 (https=) |
| DE (1) | DE60137577D1 (https=) |
| ES (1) | ES2320631T3 (https=) |
| GB (1) | GB0021147D0 (https=) |
| HR (1) | HRP20030227A2 (https=) |
| HU (1) | HUP0302910A3 (https=) |
| IL (2) | IL154302A0 (https=) |
| NO (1) | NO324944B1 (https=) |
| SK (1) | SK2342003A3 (https=) |
| WO (1) | WO2002018338A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2748140A (en) * | 1954-10-07 | 1956-05-29 | Rohm & Haas | 3-hydroxymethyl-4-phenyltetrahydro-pyridines and their esters |
| GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| CN1068597C (zh) * | 1995-05-17 | 2001-07-18 | 诺沃挪第克公司 | 制备4－芳基－哌啶衍生物的方法 |
| GB9526645D0 (en) * | 1995-12-28 | 1996-02-28 | Chiroscience Ltd | Stereoselective synthesis |
| HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
| GB9710004D0 (en) | 1997-05-17 | 1997-07-09 | Knoll Ag | Chemical process |
| DE19900576A1 (de) * | 1999-01-09 | 2000-07-13 | Merck Patent Gmbh | Benzolderivate |
-
2000
- 2000-08-30 GB GBGB0021147.4A patent/GB0021147D0/en not_active Ceased
-
2001
- 2001-08-30 ES ES01982224T patent/ES2320631T3/es not_active Expired - Lifetime
- 2001-08-30 EP EP01982224A patent/EP1315701B1/en not_active Expired - Lifetime
- 2001-08-30 IL IL15430201A patent/IL154302A0/xx unknown
- 2001-08-30 WO PCT/EP2001/009998 patent/WO2002018338A1/en not_active Ceased
- 2001-08-30 SK SK234-2003A patent/SK2342003A3/sk unknown
- 2001-08-30 DE DE60137577T patent/DE60137577D1/de not_active Expired - Lifetime
- 2001-08-30 AU AU2002213865A patent/AU2002213865A1/en not_active Abandoned
- 2001-08-30 HR HR20030227A patent/HRP20030227A2/xx not_active Application Discontinuation
- 2001-08-30 AT AT01982224T patent/ATE421953T1/de not_active IP Right Cessation
- 2001-08-30 US US10/362,531 patent/US6949650B2/en not_active Expired - Fee Related
- 2001-08-30 HU HU0302910A patent/HUP0302910A3/hu unknown
- 2001-08-30 CA CA002420579A patent/CA2420579C/en not_active Expired - Fee Related
- 2001-08-30 CZ CZ2003503A patent/CZ2003503A3/cs unknown
- 2001-08-30 JP JP2002523456A patent/JP2004518620A/ja not_active Ceased
-
2003
- 2003-02-05 IL IL154302A patent/IL154302A/en not_active IP Right Cessation
- 2003-02-25 NO NO20030876A patent/NO324944B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1315701A1 (en) | 2003-06-04 |
| IL154302A (en) | 2008-11-03 |
| GB0021147D0 (en) | 2000-10-11 |
| HRP20030227A2 (en) | 2005-02-28 |
| CA2420579A1 (en) | 2002-03-07 |
| NO324944B1 (no) | 2008-01-07 |
| WO2002018338A1 (en) | 2002-03-07 |
| EP1315701B1 (en) | 2009-01-28 |
| ES2320631T3 (es) | 2009-05-27 |
| AU2002213865A1 (en) | 2002-03-13 |
| IL154302A0 (en) | 2003-09-17 |
| US20040014786A1 (en) | 2004-01-22 |
| US6949650B2 (en) | 2005-09-27 |
| JP2004518620A (ja) | 2004-06-24 |
| CZ2003503A3 (cs) | 2003-08-13 |
| DE60137577D1 (de) | 2009-03-19 |
| HUP0302910A2 (hu) | 2004-01-28 |
| NO20030876L (no) | 2003-02-25 |
| SK2342003A3 (en) | 2003-09-11 |
| ATE421953T1 (de) | 2009-02-15 |
| NO20030876D0 (no) | 2003-02-25 |
| CA2420579C (en) | 2009-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL145742A0 (en) | Piperidine derivatives useful as ccr5 antagonists | |
| HUP0204235A3 (en) | Substituted glutarimides and use thereof il-12 production inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| IL162484A (en) | Pyrrolidine and piperidine derivatives as nk1 antagonists | |
| IL160060A0 (en) | Piperidine derivatives useful as ccr5 antagonists | |
| SI1326858T1 (sl) | Piperidinske spojine kot antialergiki | |
| IL195011A0 (en) | Process for preparing piperidine derivatives | |
| IL143858A (en) | 4-(aminomethyl)-piperidine benzamides, process for their preparation and pharmaceutical compositions containing them | |
| AU2003260744A1 (en) | 1, 4- substituted piperidine derivatives and use thereof as base-inhibitors in treatment of alzheimer's disease | |
| PL352432A1 (en) | Neurothrophic pyrolydines and piperidines, their affinite composition and methods of using them | |
| PT1401816E (pt) | Processo de produção do derivado de piperidina fexofenadina | |
| AU1204797A (en) | Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine | |
| HUP0204394A3 (en) | Tetrahydropyridines, process for their preparation, pharmaceutical compositions containing them and use thereof | |
| MXPA03009806A (es) | Derivados de piperazino y su uso como inhibidor de fosfodiesterasa de nucleotido ciclico de tipo 4 (pde4). | |
| HUP0101875A3 (en) | Process for the preparation of piperidine derivatives | |
| HUP9800707A3 (en) | Phenoxymethyl piperidine derivatives, process for producing them, and pharmaceutical compositions containing them | |
| HUP0302910A3 (en) | Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine | |
| HUP0201673A3 (en) | Process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-alpha, alpha-dimethylbenzeneacetic acid | |
| IL188916A0 (en) | Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-ylidene]methylpiperidine | |
| PL350243A1 (en) | (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same | |
| AU1048602A (en) | Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine | |
| EP1316549A4 (en) | 1-BENZYL-4 - [(5,6-DIMETHOXY-2-FLUORO-1-INDANONE) -2-YL] METHYLPIPERIDIN | |
| EP1841739B8 (en) | Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine or salt thereof via novel intermediate | |
| AU2001289851A1 (en) | Process for the racemisation of an intermediate useful in the preparation of paroxetine | |
| AU5135600A (en) | Process for producing piperidine | |
| PL364415A1 (en) | Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |